483Emergent BioSolutions Canada Inc.
Emergent BioSolutions Canada Inc. – FDA 483, Aug 27, 2025
Record Details
An FDA inspection of Emergent BioSolutions Canada Inc. in Winnipeg, MB, from August 19-27, 2025, revealed significant deficiencies in procedures designed to prevent microbiological contamination of sterile drug products. The firm lacked adequate operator monitoring, sterile gowning, cleaning protocols, and environmental controls in critical manufacturing areas, increasing the risk of product contamination.
ID · 75506747-dd4b-4d84-81b6-12f978febec5
Comes with the profile
KRA (KeyPedia Risk Analysis)
How likely the FDA is to take enforcement action in the next 12 months.
Example18-month trend
Form 483 · August 27, 2025
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Emergent BioSolutions Canada Inc. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA